Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Distress and Opioid Reward
NCT06485817Phase 1Completed
- Sponsor
- University of Oslo
- Start
- Nov 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxycodone in pain (4 arms), sponsored by University of Oslo. Primary endpoints: Amount of oxycodone self-administered, Self-report of oxycodone wanting and 1 more. Started Nov 2021; status: completed.
02
Drugs
oxycodone
03
Conditions
pain
Beyond the preview
Go deeper on NCT06485817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06485817.